PPARgamma was originally identified to stimulate the renin production during screening of the effect of free fatty acids on renin in an attempt to identify mechanisms responsible for the development of arterial hypertension during obesity [18]. This evidence concerns the gene REN and obesity due to melanocortin 4 receptor deficiency.